Mecasermin Terminated Phase 3 Trials for Growth Disorders Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00330668Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency